Hormonal and Metabolic Studies in a Patient with a Pheochromocytoma

Publisher Website
Google Scholar
Abstract
The metabolic and hormonal responses to oral glucose were studied in a patient with a pheochromocytoma before treatment, after α-blockade, after combined α- and β- blockade, and after surgical removal of the tumor. Before treatment, fasting blood glucose was elevated [6.5 mmol/liter (117 mg/dl); normal range, 4.2–5.5 mmol/liter (75–100 mg/dl)], as was the fasting plasma nonesterified fatty acid level (1.19 mmol/ liter; normal range, 0.06–0.7 mmol/liter), the blood total ketone body concentration (0.50 mmol/liter; normal range, 0.02–0.44 mmol/liter) and the lactate to pyruvate ratio (16.2; normal range, 5.9–15.01. These abnormalities were corrected by a-adrenergic blockade alone and together with β-blockade. Oral glucose tolerance (50 g) was mildly impaired in the untreated state, and the insulin response was decreased. Both α- and α- plus β- blockade restored the insulin response to glucose but failed to correct the glucose intolerance. Three months after removal of the tumor, all metabolic findings were normal. The correction of the fasting metabolite concentrations and serum insulin levels by α-adrenergic blockade suggests that an α-adenergic effect causes the original metabolic abnormalities. The residual glucose intolerance after adrenergic blockade may result from incomplete blockade or factors other than α- and β-adrenergic activity.